Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRS-080 in anemic CKD patients on hemodialysis
NCT03325621Phase 2Completed
- Sponsor
- Pieris Pharmaceuticals
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of PRS-080 in anemia of chronic kidney disease (CKD-A), sponsored by Pieris Pharmaceuticals. Started Sep 2017; status: completed.
02
Drugs
PRS-080
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03325621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325621.